Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breakthrough Infections after Postexposure Vaccination against Mpox.
Thy M, Peiffer-Smadja N, Mailhe M, Kramer L, Ferré VM, Houhou N, Tarhini H, Bertin C, Beaumont AL, Garé M, Le Pluart D, Perrineau S, Rahi M, Deconinck L, Phung B, Mollo B, Cortier M, Cresta M, De La Porte Des Vaux C, Joly V, Lariven S, Rioux C, Somarriba C, Lescure FX, Charpentier C, Yazdanpanah Y, Ghosn J. Thy M, et al. Among authors: perrineau s. N Engl J Med. 2022 Dec 29;387(26):2477-2479. doi: 10.1056/NEJMc2211944. Epub 2022 Dec 7. N Engl J Med. 2022. PMID: 36477495 No abstract available.
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study.
Mailhe M, Beaumont AL, Thy M, Le Pluart D, Perrineau S, Houhou-Fidouh N, Deconinck L, Bertin C, Ferré VM, Cortier M, De La Porte Des Vaux C, Phung BC, Mollo B, Cresta M, Bouscarat F, Choquet C, Descamps D, Ghosn J, Lescure FX, Yazdanpanah Y, Joly V, Peiffer-Smadja N. Mailhe M, et al. Among authors: perrineau s. Clin Microbiol Infect. 2023 Feb;29(2):233-239. doi: 10.1016/j.cmi.2022.08.012. Epub 2022 Aug 23. Clin Microbiol Infect. 2023. PMID: 36028090 Free PMC article.
Complicated scarring following mpox infection.
Bertin C, Tarhini H, Rahi M, Deconinck L, Perrineau S, Merlant M, Ghosn J, Peiffer-Smadja N. Bertin C, et al. Among authors: perrineau s. Br J Dermatol. 2023 Jul 17;189(2):225-226. doi: 10.1093/bjd/ljad126. Br J Dermatol. 2023. PMID: 37071783 No abstract available.
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).
Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Bousmah MA, et al. Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23. Pharmacoeconomics. 2021. PMID: 33355914 Free PMC article.
A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects.
Perrineau S, Ghesquière T, Charles P, Paule R, Samson M, Gayraud M, Chauvin A, Terrier B, Guillevin L, Bonnotte B, Mouthon L, Régent A; French Vasculitis Study Group (FVSG). Perrineau S, et al. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):155-160. doi: 10.55563/clinexprheumatol/0nd4kk. Epub 2021 Apr 30. Clin Exp Rheumatol. 2021. PMID: 33938796 Free article.
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.
Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, Lantche Wandji M, Tetsa Tata D, Omgba Bassega P, Abong Bwenda T, Varloteaux M, Tongo M, Mpoudi-Ngolé E, Montoyo A, Mercier N, LeMoing V, Peeters M, Reynes J, Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Calmy A, et al. Among authors: perrineau s. Lancet HIV. 2020 Oct;7(10):e677-e687. doi: 10.1016/S2352-3018(20)30238-1. Lancet HIV. 2020. PMID: 33010241 Clinical Trial.
14 results